Latest News and Press Releases
Want to stay updated on the latest news?
-
EDINBURGH, United Kingdom and CAMBRIDGE, United Kingdom, Nov. 25, 2025 (GLOBE NEWSWIRE) -- Macomics Ltd, a leader in macrophage drug discovery, announces that it has validated its ENIGMAC™ platform...
-
Media ReleaseCOPENHAGEN, Denmark; November 24, 2025Genmab A/S (Nasdaq: GMAB) announced today that its Chief Financial Officer Anthony Pagano will participate in a fireside chat at the Citi Global...
-
EZVIZ includes the widely-chosen smart cameras, smart locks and video doorphones in this massive markdown, making smart living more accessible than ever.
-
Company Announcement COPENHAGEN, Denmark; November 20, 2025 – Genmab A/S (Nasdaq: GMAB) announced today that the Board of Directors decided to grant 6,933 restricted stock units and 7,377 warrants to...
-
Company Announcement COPENHAGEN, Denmark; November 19, 2025 – Genmab A/S (Nasdaq: GMAB) - In accordance with Article 19 of Regulation No. 596/2014 on Market Abuse and Implementing Regulation...
-
Millburn, NJ, Nov. 19, 2025 (GLOBE NEWSWIRE) -- Healthcare professionals and members of the public from New Jersey and beyond received timely information and practical guidance in the fight against...
-
NEW YORK, Nov. 19, 2025 (GLOBE NEWSWIRE) -- Cellectis (the “Company”) (Euronext Growth: ALCLS – NASDAQ: CLLS), a clinical-stage biotechnology company using its pioneering gene-editing platform to...
-
Company Announcement COPENHAGEN, Denmark; November 18, 2025 – Genmab A/S (Nasdaq: GMAB) will increase its share capital by 32,059 shares as a consequence of the exercise of employee warrants. The...
-
Company Announcement EPKINLY plus rituximab and lenalidomide (EPKINLY + R2) is the first and only bispecific-based therapy approved by the FDA for follicular lymphoma in the second-line settingIn the...
-
NEW YORK, Nov. 18, 2025 (GLOBE NEWSWIRE) -- More people are rediscovering the joy of connecting close to home by baking for neighbors, sharing meals, and building real friendships. Among them are...